Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites

Press/Media: Press / Media

PeriodJul 28 2020

Media coverage

11

Media coverage

  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletMorningstar.com
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletMarketScreener.com
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletBioSpace
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletJotup
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletSpoke.com
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletValuespectrum.com
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletGlobeNewswire
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletBizWire Express
    CountryIndia
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletEIN News
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitleCompletes Fifth Dose Escalation Cohort of the ReSPECT(TM) Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletMarket News Publishing
    CountryUnited States
    Date7/28/20
    PersonsAndrew Brenner
  • TitlePlus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial Sites
    Media name/outletBiotechgate
    CountrySwitzerland
    Date7/28/20
    PersonsAndrew Brenner